PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.\', \'Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.\', \'Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.\', \'Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.\', \'Department of Critical Care, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.\', \'Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.\', \'Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.\', \'Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.\', \'Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: boirea@mskcc.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1535-6108(21)00051-910.1016/j.ccell.2021.01.007
?:hasPublicationType
?:journal
  • Cancer cell
is ?:pmid of
?:pmid
?:pmid
  • 33508216
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 12.7
?:rankingScore_hIndex
  • 284
is ?:relation_isRelatedTo_publication of
?:title
  • Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all